Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Symbicort vs Formoterol vs Placebo in Severe COPD (CODEX)
NCT00489853Phase 4Completed
- Sponsor
- AstraZeneca
- Start
- Jul 2007
- Primary completion
- Aug 2008
- Modality
- Orthosteric Ligands
- Countries
- 2
01
Overview
A Phase 4 trial of budesonide + formoterol in chronic obstructive pulmonary disease (COPD), sponsored by AstraZeneca. Started Jul 2007; status: completed.
02
Drugs
budesonide + formoterol
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT00489853.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00489853.